Maybe. The Food and Drug Administration (FDA) has approved Afinitor to treat advanced hormone receptor-positive, HER2-negative breast cancer in females* who have gone through menopause.
In theory, Afinitor could be used to treat this cancer in females who haven’t yet gone through menopause. Although Afinitor isn’t currently approved for this use, a clinical study is looking at this treatment option.
If you haven’t yet reached menopause and want to learn more about Afinitor, talk with your doctor.